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Background. It is well known that the programmed intermittent epidural bolus (PIEB) technique effectively provides epidural
anesthesia in labor. This randomized double-blind trial compared the postoperative analgesic efficacy of PIEB with that of
continuous epidural infusion (CEI) in patients undergoing gynecological surgery under combined general-epidural anesthesia.
Methods. Patients undergoing open gynecological surgery under combined general-epidural anesthesia were randomized at a 1 : 1
ratio to receive PIEB or CEI. In the PIEB group, the pump delivered 4mL ropivacaine 0.2% plus fentanyl 2 𝜇g/mL every hour. In
the CEI group, the pump delivered the same solution at a rate of 4mL/h. In both groups, additional 4mL boluses of ropivacaine
0.2% plus fentanyl 2 𝜇g/mL were provided, when necessary, by patient-controlled epidural analgesia after surgery. The primary
outcome was the total ropivacaine dose 40 hours after surgery. The secondary outcomes were the number of PCEA boluses and
postoperative pain (evaluated on an 11-point numerical rating scale) 3, 24, and 48 hours after surgery. Results. In total, 57 patients
were randomized (𝑛 = 28 and 29 in the PIEB and CEI groups, resp.). The two groups differ significantly in terms of the total
ropivacaine dose 40 hours after surgery (mean (standard deviation): 155.38 (4.55) versus 159.73 (7.87)mL, 𝑃 = 0.016). Compared
to the CEI group, the PIEB group had significantly lower numerical rating scale scores 3 hours (median [lower–upper quartiles]: 0
[0–0.5] versus 3 [0–5.5], 𝑃 = 0.002), 24 hours (1 [0–2] versus 3 [1–4], 𝑃 = 0.003), and 48 hours (1 [0–2] versus 2 [2–3.5], 𝑃 = 0.002)
after surgery. Conclusion. PIEB was better than CEI in terms of providing postoperative analgesia after open gynecological surgery
under combined general-epidural anesthesia.
1. Introduction
Epidural infusion is an effective neuraxial analgesic tech-
nique that has been used to manage postoperative pain for
decades [1]. In recent years, the efficacy of the programmed
intermittent epidural bolus (PIEB) technique has been well
demonstrated for labor analgesia [2–9]. PIEB is an automated
method of administering boluses of local anesthetic solution
to the epidural space at fixed, scheduled time intervals.
PIEB prolongs the duration of analgesia, reduces motor
block, lowers the incidence of breakthrough pain, improves
maternal satisfaction, and decreases local anesthetic con-
sumption compared with continuous epidural infusion (CEI)
[5, 6].
Several studies have shown the benefits of PIEB compared
withCEI in different types of surgery.Ueda et al. reported that
PIEB using ropivacaine 0.75% resulted in a more extensive
dermatomal spread as measured by loss of sensation com-
pared with CEI following gynecologic surgery [10]. Kang et
al. found that PIEB using bupivacaine 0.125% and morphine
0.005% resulted in lower numerical rating scale (NRS) scores
for pain compared with CEI following total knee arthroplasty
[11].
However, it remains unclear whether PIEB provides
superior postoperative analgesia following open surgeries
under combined general-epidural anesthesia. In this study,
we compared the efficacy of postoperative analgesia using
PIEB versus CEI with patient-controlled epidural analgesia
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(PCEA) at 3, 24, and 48 hours after surgery. We also
investigated the number of PCEA boluses and the incidence
of complications.
2. Materials and Methods
2.1. Patients and Study Protocol. The study was approved
by the Human Research Ethics Committee of Tokushima
University and was registered in a clinical trials data base
(UMIN000018881). We conducted a randomized, double-
blind clinical trial from June 2016 to August 2017. Written
informed consent was obtained from all patients, and the
study was conducted in accordance with the principals
outlined in the Declaration of Helsinki.
The recruited patients were women with myoma or
gynecological cancer who were between 20 and 80 years of
age, had an American Society of Anesthesiologists Physical
Status (ASAPS) of I–III, andwere scheduled to undergo open
gynecological surgery that involved a lower midline skin
incision that was less than 10 cm long or a vertical incision
above the umbilicus that was less than 20 cm long. Patients
were excluded from the study if they had any contraindication
to epidural analgesia, their ASA PS score was ≥IV, they were
<20 years old, they had received opioids, and/or consent was
not obtained. The patients were randomized at a 1 : 1 ratio to
receive either PIEB or CEI (Figure 1).
No patientsweremedicated prior to anesthesia induction.
After entering the operating room, standard monitors were
applied, including a blood pressure cuff, pulse oximetry
probe, and ECG leads. An epidural catheter was inserted
with the patient in the left lateral decubitus position at the
T10-T11 or T11-T12 interspace before anesthesia induction.
The epidural space was identified using loss of resistance to
saline technique with an 18-gauge Tuohy epidural needle.
A closed-end, multiorifice epidural catheter (Perifix FX,
BBraun, Aesculap, Tuttlingen, Germany) was advanced 5 cm
and 2mL lidocaine of 1% was administered as a test dose.
After epidural catheter placement, a blinded researcher who
set up the epidural pump according to group allocation
assigned the patient using computer-generated distribution
(Quick-Calcs, GraphPad Inc., La Jolla, CA, USA) which is
made by a statistician who was not involved in the clinical
study. The subjects and other study personnel were blinded
to group assignment and all observations and assessments
were performed by a researcher blinded to the mode of drug
administration.
General anesthesia was induced with propofol, remifen-
tanil, and rocuronium and was maintained with sevoflurane
or desflurane, remifentanil, and rocuronium. After tracheal
intubation, all patients received an initial epidural loading
dose of 6mL ropivacaine 0.2% plus fentanyl 1.6 𝜇g/mL, and
a CADD-Solis Ambulatory Infusion Pump (Smith Medical,
St Paul, MN, USA) was connected.
In the PIEB group, the pump was programmed to deliver
4mL ropivacaine 0.2% plus fentanyl 2 𝜇g/mL every hour
beginning 1 hour after the epidural loading dose. In the CEI
group, the pump was programmed to deliver ropivacaine
0.2% plus fentanyl 2 𝜇g/mL at a rate of 4mL/h beginning
immediately after the loading epidural dose (see Figure 2).
The pump was programmed and set by an anesthesiologist
who was not responsible for the anesthetic management of
the patient. Flurbiprofen axetil 1mg/kg was administered
intravenously in both groups at the end of the surgery. The
PCEA pump was programmed to deliver 4mL/h of the same
solution with a lockout interval of 1 hour and a maximum
hourly volume of 12mL. If patients requested additional
analgesics, loxoprofen 60mg was taken orally or pentazocine
15mg was administered intravenously.
2.2. Measurements. All observations and assessments were
performed by anesthesiologists who were not in charge of the
anesthetic management of this study and who were blinded
to the mode of drug administration. The primary outcome
was the total dose of ropivacaine 40 hours after surgery.
The secondary outcomes were the degree of postoperative
pain (NRS pain scores), the number of PCEA boluses, the
anesthesia range, the extent of sensory and motor block,
the presence/absence of hypotension that required treatment,
the presence/absence of postoperative nausea and vomiting
(PONV), and the dose of loxoprofen and pentazocine 3,
24, and 48 hours after surgery. The highest postoperative
pain between the prior assessment and the time of the
assessment was evaluated by an 11-point NRS (0 = no pain to
10 = the worst pain imaginable). Extent of sensory blockade
was assessed using loss of cold sensation. The number of
administered PCEA requests was recorded by the CADD-
Solis Medication System version 3 (Smith Medical, St Paul,
MN, USA) and was obtained after patients completed the
regimen. The degree of motor block was assessed in both
lower extremities using the Breen modified Bromage score
[12], whereby 1 is complete block (unable to move feet or
knees), 2 is almost complete block (only able to move feet),
3 is partial block (just able to move knees), 4 is detectable
weakness of hip flexionwhile supine (between scores 3 and 5),
5 is no detectable weakness of hip flexion while supine (full
flexion of knees), and 6 is being able to stand and perform
a partial knee bend. The severity of nausea was estimated by
the nausea score (0 = absence of nausea; 1 = mild nausea; 2 =
moderate nausea; 3 = severe nausea).
2.3. Statistical Analysis. The data from a study comparing
PIEB and CEI in terms of the total dose of ropivacaine
needed to achieve effective analgesia in labor were used
for the power calculation. This calculation was based on
mean (standard deviation) total ropivacaine doses of 104.7
(29.2)mg in the PIEB group and 124.2 (17.9)mg in the CEI
group [3]. This analysis suggested that a study with 25
patients per group would have a power of 80% to detect a
statistically significant difference in total ropivacaine dose
at an alpha of 0.05. Patients who developed complications
that prevented them from completing the trial (e.g., motor
block and epidural catheter evulsion) were excluded from
the perprotocol analysis. All data are presented as mean
(standard deviation), median (25th–75th quartile range), or
number of subjects. All analyses were performed by using the
Statistical Package for Social Sciences (SPSS) software version
22 (IBM Corp, Armonk, New York, USA).The PIEB and CEI
groups were compared by using the Chi-squared test or the
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Figure 1: Consolidated Standards of Reporting Trials (CONSORT) flow diagram indicating patient disposition during the study. PIEB,
programmed intermittent epidural bolus; CEI, continuous epidural infusion; ASA PS, American Society of Anesthesiologists Physical Status.
Mann–Whitney 𝑈 test. A 𝑃 value of <0.05 was considered to
indicate statistical significance.
3. Results
Sixty women were recruited to participate from July 2016 to
August 2017. Of these, 3 patients declined to participate in the
research and 57 patients were randomized to either the PIEB
or CEI group. In the PIEB group, motor block on the right
thigh with a modified Bromage scale score of 3 occurred in
one patient. In the CEI group, sensory block on the anterior
aspect of the right thigh and motor block on the right thigh
with a modified Bromage scale score of 3 occurred in one
patient. Accidental evulsion of the epidural catheter occurred
in one patient. In all, 54 patients completed the trial. Patient
demographics are shown in Table 1.
There was significant difference in the total dose of ropi-
vacaine 40 hours after surgery (mean (standard deviation):
155.38 (4.55) versus 159.73 (7.87)mL, 𝑃 = 0.016). NRS
scores were significantly different between the two groups
at 3 hours (median [IQR], 0 [0–0.5] versus 3 [0–5.5], 𝑃 =
0.002), 24 hours (1 [0–2] versus 3 [1–4], 𝑃 = 0.003), and 48
hours after surgery (median [IQR], 1 [0–2] versus 2 [2–3.5],
𝑃 = 0.002) (Figure 3). The number of administered PCEA
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Table 1: Baseline demographic and clinical characteristics of the programmed intermittent epidural bolus (PIEB) and continuous epidural
infusion (CEI) groups.
Variable PIEB group CEI group P value
(𝑛 = 28) (𝑛 = 29)
Age, year
30–39 3 5 0.478
40–49 7 9 0.612
50–59 7 5 0.473
60–69 8 6 0.490
70–79 3 4 0.723
Mean ± SD 54 ± 11 53 ± 12 0.669
Height, cm 156 ± 5 158 ± 7 0.196
Weight, kg 57 ± 12 60 ± 11 0.382
BMI, kg/m2 23 ± 5 24 ± 5 0.572
ASA PS I/II/III 7/20/1 12/16/1 0.418
Duration of anesthesia, min 294 ± 137 299 ± 124 0.888
Duration of surgery, min 251 ± 134 251 ± 125 0.995
Type of surgery
Myomectomy 2 4 0.413
TAH 2 3 0.669
BSO 4 2 0.363
TAH + BSO 7 6 0.698
TAH + BSO + pelvic lymph node dissection 5 4 0.674
TAH + BSO + omentectomy + pelvic para-aortic lymph node dissection 8 10 0.631
Fluid volume, mL 2563 ± 1549 2441 ± 1214 0.747
Length of hospital stay, days 12 ± 5 13 ± 7 0.589
The data are presented as mean ± SD or number of patients; ASA PS: American Society of Anesthesiologists Physical Status; BMI: body mass index; BSO:
bilateral salpingo-oophorectomy; CEI: continuous epidural infusion; PIEB: programmed intermittent epidural bolus; TAH: total abdominal hysterectomy.
boluses was significantly different between the two groups at
3 hours (median [IQR], 0 [0-0] versus 0 [0-1], 𝑃 = 0.004)
and 24 hours (median [IQR], 0 [0-0] versus 0 [0–2], 𝑃 =
0.045). The total number of PCEA boluses was significantly
different between the two groups (median [IQR], 0 [0-0]
versus 1 [0–4], 𝑃 = 0.007). The dose of oral administration of
loxoprofenwas significantly different between the two groups
at 48 hours (median [IQR], 0 [0–60] versus 60 [30–120],
𝑃 = 0.036). The total dose of loxoprofen was significantly
different between the two groups (median [IQR], 60 [0–150]
versus 120 [60–180], 𝑃 = 0.047, resp.) (Table 2).
No significant between-group difference was observed in
any of the other parameters evaluated (Table 3).
4. Discussion
In this study, we compared the efficacy of PIEB with that of
CEI for postoperative analgesia following open gynecologic
surgery. PIEB with 4mL of ropivacaine 0.2% plus fentanyl
2 𝜇g/mL every hour resulted in lower dose of ropivacaine
40 hours after surgery and NRS scores at 3, 24, and 48
hours after surgery comparedwith CEI using the same hourly
volume of the same solution. Also, the total number of PCEA
boluses was smaller in the PIEB group. Moreover, there
was no difference in the incidence of complications between
the two groups. These results suggest that PIEB can safely
provide better postoperative analgesia than CEI after open
gynecologic surgery.
The efficacy of epidural analgesia requires adequate
spread of the anesthetic solution within the epidural space
to produce sensory blockade of the appropriate dermatomes
[6]. It has been demonstrated that distribution of solution
through an epidural catheter is not uniform. The most uni-
form spread occurs with large volumes and correspondingly
high injectate pressures near the site of injection [13]. An
in vitro study using the computer-aided design and drafting
(CADD) pump showed that peak pressure was directly asso-
ciated with the delivery speed of the solution [14]. Solutions
injected into the epidural space also tend to spread more
evenly when injected as a bolus, which likely explains why
more effective analgesia was achieved in the PIEB group.
Many studies have sought to determine the optimal PIEB
regimen and pump settings [2–11]. For labor analgesia, Wong
et al. demonstrated that extending the programmed intermit-
tent bolus interval from 15 to 60 minutes and increasing the
volume from 2.5 to 10mL decreased bupivacaine consump-
tion without decreasing patient comfort or satisfaction [15].
Kanczuk et al. found that the optimal time interval between
boluses with PIEB using 10mL of bupivacaine 0.0625% plus
fentanyl 2𝜇g/mL to achieve effective analgesia in 90% of
women during the first stage of labor without breakthrough
pain was approximately 40 minutes [16]. The bolus volume
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Table 2: Postoperative medication used by the programmed intermittent epidural bolus (PIEB) and continuous epidural infusion (CEI)
groups (perprotocol analysis).
Variable PIEB group CEI group 𝑃 value
(𝑛 = 27) (𝑛 = 27)
Number of PCEA doses
3 hours 2 13 0.004
24 hours 13 33 0.045
48 hours 4 12 0.362
Total 17 60 0.007
Loxoprofen, mg, median [25th–75th quartiles]
3 hours 0 [0-0] 0 [0-0] 1.000
24 hours 0 [0–60] 60 [0–60] 0.431
48 hours 0 [0–60] 60 [30–120] 0.036
Total 60 [0–150] 120 [60–180] 0.047
Pentazocine, mg, median [25th–75th quartiles]
3 hours 0 [0-0] 0 [0-0] 1.000
24 hours 0 [0-0] 0 [0-0] 0.317
48 hours 0 [0-0] 0 [0-0] 1.000
Total 0 [0-0] 0 [0-0] 0.624
The data are presented as median (25th–75th quartiles) number of administered doses or dose; CEI: continuous epidural infusion; PCEA: patient-controlled
epidural analgesia; PIEB: programmed intermittent epidural bolus.
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Figure 2: Pump settings in the (a) programmed intermittent
epidural bolus (PIEB) and (b) continuous epidural infusion (CEI)
groups.The first arrows in both figures show the initial bolus. Other
arrows in (a) show the intermittent boluses.
and lockout period vary significantly among PIEB studies;
therefore further studies are needed to determine the optimal
regimen.
In combined general-epidural aesthesia, Ueda et al.
reported that PIEB using ropivacaine 0.75% at a dose of 1mL
every 20 minutes resulted in a more extensive dermatomal
spread, as measured by loss of sensation, in gynecologic
surgery compared with CEI using the same solution at a dose
of 3mL/h [10]. Kang et al. found that PIEBusing 3mLof bupi-
vacaine 0.125% plus morphine 0.005% every hour resulted
in lower NRS scores compared with CEI after total knee
arthroplasty [11]. In our study, we chose to use 4mL/hour
of ropivacaine 0.2% plus fentanyl 2 𝜇g/mL as the epidural
analgesic regimen during and after gynecological surgery on
the basis of these studies and a study on CEI with 0.2%
ropivacaine/hour in abdominal surgery [17]. Ropivacainewas
chosen rather than bupivacaine because it is less toxic and
generates less motor block when given by epidural infusion
[18]. The flow rate was set to a slow speed to decrease the
complications of epidural anesthesia. Our regimen of PIEB
did not require many PCEA doses or rescue analgesics,
which is consistent with previous studies [5, 6]. PIEB may
be therefore be an effective technique for both combined
general-epidural anesthesia and labor analgesia.
The two groups did not differ in terms of PONV at any
time point. This may reflect the fact that fentanyl was also
used for pain relief andmitigated the tendency of ropivacaine
to induce PONV.
Our study does have some limitations. First, we only
included patients undergoing open gynecological surgery
under combined general-epidural anesthesia. Further studies
are therefore needed to confirm the efficacy of PIEB with
different types of surgeries in different regions of the body.
Another limitation of our studywas that all study participants
were women less than 80 years old. Because pain perception
differs with gender and age [19, 20], epidural anesthesia
settings may need to be adjusted for each patient.
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Table 3: Postoperative complications in the programmed intermittent epidural bolus (PIEB) and continuous epidural infusion (CEI) groups
(intention-to-treat analysis).
Variable PIEB group CEI group P value
(𝑛 = 28) (𝑛 = 29)
3 hours
Postoperative nausea and/or vomiting 14 19 0.236
Sensory and/or motor block 1 1 0.980
Hypotension 0 0 1.000
24 hours
Postoperative nausea and/or vomiting 8 13 0.200
Sensory and/or motor block 0 0 1.000
Hypotension 0 0 1.000
48 hours
Postoperative nausea and/or vomiting 3 9 0.050
Sensory and/or motor block 0 0 1.000
Hypotension 0 0 1.000
All data are presented as total numbers; CEI: continuous epidural infusion; PIEB: programmed intermittent epidural bolus.
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Figure 3: Comparison of the programmed intermittent epidural
bolus (PIEB) and continuous epidural infusion (CEI) groups in
terms of numeric rating scale (NRS) of pain 3, 24, and 48 hours
after surgery. The data are shown as medians (lines in the boxes),
25th and 75th quartiles (bottom and top of the boxes, resp.), and the
lower and upper outlier thresholds (the ends of the whiskers on the
boxes). The lower outlier threshold was the 25th percentile minus
1.5 × the interquartile range (IQR; 75th quartile minus 25th quartile)
while the upper outlier threshold was the 75th percentile plus 1.5 ×
the IQR. ∗Significant (𝑃 < 0.05) differences between the PIEB and
CEI groups, as indicated by Mann–Whitney 𝑈 tests.
5. Conclusions
PIEB reduced the total ropivacaine dose 40 hours after
surgery. NRS scores were also significantly lower in patients
who received PIEB compared with those who received
CEI at 3, 24, and 48 hours postoperatively. PIEB therefore
provides superior postoperative analgesia to CEI following
open gynecologic surgery under combined general-epidural
anesthesia. PIEB is one of the effective analgesic techniques
for postoperative pain. To optimize the PIEB regimen, future
studies are needed.
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